Equal-parts research blend · Experimental

Wolverine Stack 20mg

BPC-157 + TB-500 · 20mg vial

A fixed 1:1 blend of two experimental peptides. This 20mg vial contains 10mg BPC-157 and 10mg TB-500, lyophilised together in one vial.

Pricing · per unit

Mix & match any vials — 2–4 −10%, 5+ −15%
Retail1 unitR800
2–4−10%R720
5+−15%R680

In transit · ETA 20 Nov

How it works

BPC-157 has been explored in angiogenesis and fibroblast-signalling models. TB-500 and thymosin beta-4-related research includes actin dynamics and cell migration. Most evidence is preclinical.

Research context

Reviews describe largely unvalidated human findings for BPC-157 and a lack of human orthopaedic data for TB-500. Evidence for the combined blend is even more limited.

Vial contents & handling

  • 10mg BPC-157
  • 10mg TB-500
  • 20mg total · 1:1 lyophilised blend

Quality & sourcing. Sourced from established manufacturers who test using HPLC analysis. COA available on request — ask us on WhatsApp ↗

Storage: keep unopened lyophilised vials in a cool, dark place. Once reconstituted, store in the fridge at 2–8°C and use within 2 months.

Research reference dosage

20mg vial · 3ml water · 6.67mg/ml
LevelAmountU100 unitsFrequency
Beginner250mcg total3.75 unitsOnce daily · 4 weeks · morning
Intermediate500mcg total7.5 unitsOnce daily · 4–6 weeks · morning
Advanced1mg total15 unitsOnce daily · 4–6 weeks · morning, or 500mcg twice daily

Fixed 3ml · U100 device (1 unit = 0.01ml). Amounts are total blend; each component is half. Advanced alternative: 500mcg = 7.5 units per administration, twice daily. Research reference only.

Dosing status: No established human dosing standard or evidence-based beginner schedule for this blend.

References

Guides

Research use only · Not for human or veterinary consumption · Not for self-administration